Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2007
06/05/2007US7226768 Cytochrome P450 oxygenases
06/05/2007US7226767 Process for producing cytidine diphosphate choline
06/05/2007US7226764 utilization of recombinant enzymes from Arabidopsis thaliana, UDP-glucose, and a sulfur donor to synthesize UDP-SQ, and the subsequent modification of UDP-SQ to form compounds including, but not limited to, 6-sulfo- alpha -D-quinovosyl diaclyglycerol (SQDG) and alkyl sulfoquinovoside
06/05/2007US7226763 Nucleotide sequences coding enzymatic polypeptide; for use in generation of preferential amino acids
06/05/2007US7226762 Gene coding for glucose-6-phosphate-dehydrogenase proteins
06/05/2007US7226756 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
06/05/2007US7226745 Plant vitamin E biosynthetic enzymes
06/05/2007US7226742 Method for detecting base mutation
06/05/2007US7226737 Polynucleotides for use as tags and tag complements, manufacture and use thereof
06/05/2007US7226733 Biosensor for use detection of preferential particles in sample
06/05/2007US7226602 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever
06/05/2007US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
06/05/2007CA2394018C Bzip transcription factor that controls expression of the storage protein in the rice plant
06/05/2007CA2320666C 5' nucleases derived from thermostable dna polymerase
06/05/2007CA2284555C Probes for the diagnosis of infections caused by streptococcus pyogenes
06/05/2007CA2214431C Human vegf-specific antisense oligonucleotides
06/05/2007CA2181165C Anti-fungal methods and materials
06/05/2007CA2143442C Dorsal tissue affecting factor and compositions
06/05/2007CA2128530C Method for use of branched nucleic acid probes
06/05/2007CA2080812C Hybridization probes derived from the spacer region between the 16s and 23s rrna genes for the detection of non-viral microorganisms
05/2007
05/31/2007WO2007059816A1 Polynucleotide containing a phosphate mimetic
05/31/2007WO2007014469A8 Hepatitis c antivirals
05/31/2007WO2007005840A3 Compositions, kits and methods pertaining to stability modulation of pna oligomer/nucleic acid complexes
05/31/2007WO2006116458A3 Modified oligoribonucleotide analogs with enhances immunostimulatory activity
05/31/2007WO2006081311A3 Compositions and methods for the intracellular disruption of vegf and vegfr-2 by intraceptors
05/31/2007WO2006076102A3 Fluorescent nucleoside analogs that mimic naturally occurring nucleosides
05/31/2007WO2006069290A3 Enzymes for starch processing
05/31/2007WO2006069289A3 Polypeptides having glucoamylase activity and polynucleotides encoding same
05/31/2007WO2006066154A3 Casein kinase 2 antisense therapy
05/31/2007WO2006055727A3 MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS
05/31/2007WO2006042418A9 Antiviral oligonucleotides
05/31/2007WO2006033854A3 Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
05/31/2007WO2005094338A3 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
05/31/2007WO2005072152A3 Apoc1 genetic markers associated with age of onset of alzheimer's disease
05/31/2007WO2005012500A3 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology
05/31/2007WO2005003316A3 Rna processing protein complexes and uses thereof
05/31/2007WO2002094185A3 Conjugates and compositions for cellular delivery
05/31/2007US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof
05/31/2007US20070124836 Methods for genetic control of insect infestations in plants and compositions thereof
05/31/2007US20070124834 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake
05/31/2007US20070124829 Avians containing a lysozyme promoter transgene
05/31/2007US20070124828 Allelic form of the HMGA2 gene predisposing women to the formation of Leiomyomas
05/31/2007US20070123703 includes a 5'-deblocking step in which the 5-blocking group is removed with dichloroacetic acid that is essentially free of chloral; improved purity
05/31/2007US20070123702 Oligonucleotdies having A-DNA form and B-DNA form conformational geometry
05/31/2007US20070123486 Composition for coordinated VEGF and PDGF expression, and methods of use
05/31/2007US20070123485 Introduction of double-stranded short interference RNA into the cells and reducing the expression of the corresponding messenger RNA in the cells; for inhibiting expression of a target gene in a cell
05/31/2007US20070123484 Double strand compositions comprising differentially modified strands for use in gene modulation
05/31/2007US20070123481 Antisense IAP oligonucleotides and uses thereof
05/31/2007US20070123467 Amniotic-derived peptide and uses thereof
05/31/2007US20070123457 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof
05/31/2007US20070123456 Novel regulator of endothelial cell function and vessel remodeling
05/31/2007US20070122887 Gene variants coding for proteins from the metabolic pathway of fine chemicals
05/31/2007US20070122884 Factor VII glycoforms
05/31/2007US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders
05/31/2007US20070122882 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
05/31/2007US20070122881 Rhamnose-inducible expression systems and methods
05/31/2007US20070122880 Vector for the inducible expression of gene sequences
05/31/2007US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4
05/31/2007US20070122878 Human orphan G protein-coupled receptors
05/31/2007US20070122875 Enzyme for decomposition of sulfated fucan derived from sea cucumber
05/31/2007US20070122868 Drug screening; identifying potential biological targets for fungicides and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley
05/31/2007US20070122866 Protein having PGE2 synthase activity and use thereof
05/31/2007US20070122865 Enzymes and enzymic processes
05/31/2007US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
05/31/2007US20070122849 Rhesus monkey P2X7 purinergic receptor and uses thereof
05/31/2007US20070122837 Mothod for the synthesis of DNA sequences
05/31/2007US20070122835 Determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at the locus of interest, wherein the ratio indicates the presence or absence of a chromosomal abnormality; noninvasive; determining the sequence of DNA from a fetus
05/31/2007US20070122832 Process for Preparing L-amino Acids
05/31/2007US20070122828 Short cycle methods for sequencing polynucleotides
05/31/2007US20070122826 Minimal bacterial genome
05/31/2007US20070122825 Method to predict the response to lithium treatment
05/31/2007US20070122816 Microarray comprising qc probes and method for fabricating the same
05/31/2007US20070122810 Brain tumor marker and method of diagnosing brain tumor
05/31/2007US20070122809 Nucleic acid isolation
05/31/2007US20070122807 Posh polypeptides, complexes and related methods
05/31/2007US20070122806 Predicting graft rejection
05/31/2007US20070122804 Combined exponential and linear amplification
05/31/2007US20070122803 Methods for the detection of polymorphisms in the human oatpf gene
05/31/2007US20070122428 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection
05/31/2007US20070122425 fusion protein comprising a periplasmic targeting signal and at least one antimicrobial peptide; use as microbiocides; from Gram negative bacteria transformed host cell; nontoxic and proteolytic non-degradation, simple, inexpensive recovery of the peptide; industrial scale production; on medical devices
05/31/2007US20070122423 Derp1 and proderp1 allergen derivatives
05/31/2007US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids
05/31/2007US20070122421 Flagellin fusion for use in generating vaccines for prevention and treatment of tumors, allergens and nervous system disorders
05/31/2007US20070122412 Eg-vegf nucleic acids and polypeptides and methods of use
05/31/2007US20070122405 Human G-protein chemokine receptor (CCR5) HDGNR10
05/31/2007US20070122404 Humanized immunoglobulin reactive with alpha4beta7 integrin
05/31/2007US20070122403 Molecules with extended half-lives, compositions and uses thereof
05/31/2007US20070122401 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
05/31/2007US20070122380 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use
05/31/2007CA2790802A1 Immunostimulatory oligoribonucleotides
05/31/2007CA2630974A1 Methods and compositions involving intrinsic genes
05/31/2007CA2630814A1 Methods and compositions for sequencing a nucleic acid
05/30/2007EP1790736A2 Massive parallel method for decoding DNA and RNA
05/30/2007EP1790717A2 Compositions and methods for the identification of lung tumor cells
05/30/2007EP1789589A2 Detection of nucleic acid differences using endonuclease cleavage/ligas releasing reactions and capillary electrophoresis or microarrays
05/30/2007EP1789578A2 Cleavable solid phases for isolating nucleic acids
05/30/2007EP1789553A2 Oligonucleotides comprising a non-phosphate backbone linkage
05/30/2007EP1789451A2 Tie complex binding proteins
05/30/2007EP1789096A2 Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
05/30/2007EP1789058A2 Rna interference vectors